These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients. Katugampola RP; Finlay AY Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796 [TBL] [Abstract][Full Text] [Related]
4. Acitretin for the treatment of psoriasis: an assessment of national trends. Ghasri P; Yentzer BA; Dabade TS; Feldman SR J Drugs Dermatol; 2011 Aug; 10(8):873-7. PubMed ID: 21818508 [TBL] [Abstract][Full Text] [Related]
5. Use of retinoids in the treatment of psoriasis. Warren EW; Khanderia U Clin Pharm; 1989 May; 8(5):344-51. PubMed ID: 2663325 [TBL] [Abstract][Full Text] [Related]
7. Erythroderma in a patient taking acitretin for plaque psoriasis. Ahdout J; Mandel H; Chiu M J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522 [TBL] [Abstract][Full Text] [Related]
8. [Etretinate: pro and con. Risk-benefit analysis of systemic retinoid therapy in psoriasis and recent developments: free aromatic acid, arotinoids]. Gollnick H; Orfanos CE Hautarzt; 1985 Jan; 36(1):2-9. PubMed ID: 3156105 [TBL] [Abstract][Full Text] [Related]
9. [Treatment with retinoids]. Berbis P Rev Prat; 1991 Oct; 41(22):2180-1. PubMed ID: 1784920 [TBL] [Abstract][Full Text] [Related]
10. New roles for systemic retinoids. Lebwohl M; Kathryn M J Drugs Dermatol; 2006 May; 5(5):406-9. PubMed ID: 16703775 [TBL] [Abstract][Full Text] [Related]
11. Retinoids and phototherapy for psoriasis. Monfrecola G; Baldo A J Rheumatol Suppl; 2009 Aug; 83():71-2. PubMed ID: 19661548 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tazarotene and acitretin in psoriasis. Heath MS; Sahni DR; Curry ZA; Feldman SR Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):919-927. PubMed ID: 30134735 [TBL] [Abstract][Full Text] [Related]
13. Acitretin revisited in the era of biologics. Booij MT; Van De Kerkhof PC J Dermatolog Treat; 2011 Apr; 22(2):86-9. PubMed ID: 20673152 [TBL] [Abstract][Full Text] [Related]
14. The treatment of psoriasis with etretinate and acitretin: a follow up of actual use. Magis NL; Blummel JJ; Kerkhof PC; Gerritsen RM Eur J Dermatol; 2000; 10(7):517-21. PubMed ID: 11056421 [TBL] [Abstract][Full Text] [Related]
15. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. Halverstam CP; Zeichner J; Lebwohl M J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599 [TBL] [Abstract][Full Text] [Related]
16. Acitretin prescribing patterns in women of childbearing potential. Davis SA; Yentzer BA; Feldman SR J Drugs Dermatol; 2013 Jul; 12(7):799-802. PubMed ID: 23884494 [TBL] [Abstract][Full Text] [Related]
17. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management]. Sukarovska BG; Lipozencić J; Vrzogić P Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of acitretin in severe psoriasis. Geiger JM Skin Therapy Lett; 2003; 8(4):1-3, 7. PubMed ID: 12858231 [TBL] [Abstract][Full Text] [Related]
19. Oral retinoids--efficacy and toxicity in psoriasis. Gollnick HP Br J Dermatol; 1996 Oct; 135 Suppl 49():6-17. PubMed ID: 9035704 [TBL] [Abstract][Full Text] [Related]
20. Comparative tolerability of systemic treatments for plaque-type psoriasis. McClure SL; Valentine J; Gordon KB Drug Saf; 2002; 25(13):913-27. PubMed ID: 12381213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]